{"id":830221,"date":"2026-11-10T15:48:15","date_gmt":"2026-11-10T15:48:15","guid":{"rendered":"https:\/\/www.newsbeep.com\/uk\/830221\/"},"modified":"2026-11-10T15:48:15","modified_gmt":"2026-11-10T15:48:15","slug":"access-to-major-drugs-mixed-when-it-comes-to-major-diseases","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/uk\/830221\/","title":{"rendered":"Access to major drugs mixed when it comes to major diseases"},"content":{"rendered":"<p class=\"author-bio\">Ed\u2019s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning <a href=\"https:\/\/www.statnews.com\/signup\/pharmalittle\/\" rel=\"nofollow noopener\" target=\"_blank\">Pharmalittle newsletter<\/a> and the afternoon <a href=\"https:\/\/www.statnews.com\/signup\/pharmalot\/\" rel=\"nofollow noopener\" target=\"_blank\">Pharmalot newsletter<\/a>.<\/p>\n<p class=\"wp-block-paragraph\">Many large pharmaceutical companies are taking steps to improve access to their medicines in low- and middle-income countries, but progress has been mixed and more action is needed to ensure wide availability, a new analysis found.<\/p>\n<p class=\"wp-block-paragraph\">Notably, more drugmakers are planning to reach patients before a product launch \u2014 access plans now cover 69% of late-stage pipeline candidates compared with 18% in 2018. And across the pipeline, 95% of late-stage experimental drugs developed with a nonprofit partner have an access plan in place, versus 67% without such a partner.<\/p>\n<p>\t\t\t<img decoding=\"async\" width=\"768\" height=\"432\" src=\"https:\/\/www.newsbeep.com\/uk\/wp-content\/uploads\/2026\/11\/AdobeStock_81252269-768x432.jpeg\" class=\"attachment-article-main-medium-large size-article-main-medium-large\" alt=\"\" loading=\"lazy\"  \/>\t\t<\/p>\n<p>\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.statnews.com\/wp-content\/themes\/stat\/images\/home\/statplus.svg\" width=\"19\" height=\"16\" alt=\"\"\/><br \/>\n\t\t\t\t<a href=\"https:\/\/www.statnews.com\/pharmalot\/2023\/09\/29\/generics-biosimilar-access-poor-medicines-teva-hikma-viatris-cipla-sun\/\" rel=\"nofollow noopener\" target=\"_blank\">STAT Plus: Generic makers fall short when providing access to low- and middle-income countries, analysis finds<\/a><\/p>\n<p class=\"wp-block-paragraph\">Another bright spot involves cancer treatments. Access plans now cover 65% of cancer drugs in product pipelines, up from 5% in 2018. But 43% of access plans for non-communicable diseases \u2014 specifically, sickle cell disease, diabetes, and mental health \u2014 focus solely on regulatory registrations and primarily in wealthy countries.<\/p>\n<p class=\"restricted-text\">STAT+ Exclusive Story<\/p>\n<p class=\"restricted-login\">Already have an account? <a href=\"https:\/\/www.statnews.com\/login\/\" data-stat-login=\"\" data-stat-paywall-cta=\"breaker login cta\" rel=\"nofollow noopener\" target=\"_blank\">Log in<\/a><\/p>\n<p>\t\t\t<img decoding=\"async\" class=\"restricted-content-breaker-bg\" src=\"https:\/\/www.newsbeep.com\/uk\/wp-content\/uploads\/2026\/11\/1794325694_739_stat-plus-breaker-bg.png\" alt=\"STAT+\"\/><\/p>\n<p>\t\t\t\t\t<a href=\"https:\/\/www.statnews.com\/stat-plus\/\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n\t\t\t\t\t\t<img decoding=\"async\" class=\"stat-plus-logo\" src=\"https:\/\/www.statnews.com\/wp-content\/themes\/stat\/images\/stat-plus-logo-white.svg\" alt=\"STAT+\"\/><br \/>\n\t\t\t\t\t<\/a><\/p>\n<p>\t\t\t\tThis article is exclusive to STAT+ subscribers<br \/>\n\t\t\t\tUnlock this article \u2014 plus in-depth analysis, newsletters, premium events, and news alerts.<\/p>\n<p class=\"restricted-content-breaker-wrapper-cta mobile\">Already have an account? <a href=\"https:\/\/www.statnews.com\/login\/\" data-stat-login=\"\" data-stat-paywall-cta=\"breaker login cta mobile\" rel=\"nofollow noopener\" target=\"_blank\">Log in<\/a><\/p>\n<p>\t\t\t\t\t\tIndividual plans<\/p>\n<p>\t\t\t\t\t\tGroup plans<\/p>\n<p>\t\t\t\t<a href=\"https:\/\/www.statnews.com\/stat-plus\/\" class=\"stat-button view-all\" data-stat-paywall-cta=\"breaker view all plans\" aria-label=\"View All Plans\" rel=\"nofollow noopener\" target=\"_blank\">View All Plans<\/a><\/p>\n<p class=\"restricted-content-text\">\n\t\t\t\t\t\tTo read the rest of this story subscribe to STAT+.\t\t\t\t\t<\/p>\n<p>\t\t\t\t\t<a href=\"https:\/\/www.statnews.com\/stat-plus\/\" class=\"stat-button restricted-button\" data-stat-paywall-cta=\"breaker subscribe cta 1\" rel=\"nofollow noopener\" target=\"_blank\">Subscribe<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Ed\u2019s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He&hellip;\n","protected":false},"author":2,"featured_media":830222,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[42],"tags":[3252,102,6591,13214,305,650,57202,56,54,55],"class_list":["post-830221","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-biotechnology","tag-health","tag-medication","tag-pharmaceuticals","tag-policy","tag-public-health","tag-stat","tag-uk","tag-united-kingdom","tag-unitedkingdom"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts\/830221","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/comments?post=830221"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts\/830221\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/media\/830222"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/media?parent=830221"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/categories?post=830221"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/tags?post=830221"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}